[1]CurrentPatentAssignee:NANJINGUNIVERSITYOFSCIENCEANDTECHNOLOGY-CN109384677,2019,A
[1]CurrentPatentAssignee:NANJINGUNIVERSITYOFSCIENCEANDTECHNOLOGY-CN109384677,2019,ALocationinpatent:Paragraph0059-0062
[1]Wakchaure,VijayN.;Obradors,Carla;List,Benjamin[Synlett,2020,vol.31,#17,p.1707-1712]
403-37-2 
 
6-(4-cyanophenyl)-1-(2-morpholinoethyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylicacid 
 
6-(4-cyanophenyl)-N-(1-(4-fluorophenyl)ethyl)-1-(2-morpholinoethyl)-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
[1]CurrentPatentAssignee:TEONTHERAPEUTICS-WO2021/226206,2021,A2Locationinpatent:Paragraph0657-0661
403-37-2 
 
1-((5-fluoropyridin-2-yl)methyl)-2-oxo-6-(prop-1-en-2-yl)-1,2-dihydro-1,8-naphthyridine-3-carboxylicacid 
 
(R)-N-(1-(4-fluorophenyl)ethyl)-1-((5-fluoropyridin-2-yl)methyl)-2-oxo-6-(prop-1-en-2-yl)-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
[1]CurrentPatentAssignee:TEONTHERAPEUTICS-WO2021/226206,2021,A2Locationinpatent:Paragraph1174;1183-1187